Roche released Phase III trial data on its new multiple sclerosis drug, ocrelizumab, which appears to have an advantage over other MS drugs. It's been shown to treat primary progressive multiple sclerosis (PPMS) the more severe, and previously untreatable, form of the disease. No other drug does this.
A new study, released this week and slated to be presented at the American Academy of Neurology meetings in April, found a link between coffee consumption a lot of it and a reduced incidence of multiple sclerosis. It s a pretty slim thread, however.
The latest in health news: The Pennsylvania Environmental Protection Agency releases review on low-risk fracking, a stem cell transplant method provides new hope for MS treatment, & why Golden Rice mustn't be stopped.
Multiple sclerosis (MS) is an unpredictable, disabling disease of the central nervous system. In its severest form, MS may impair locomotion, vision, bladder function, and even respiratory function, and can be fatal. Many experts estimate that up to 400,000 Americans have MS.
Currently, the efficacy of stem cell transplantation in preventing the progression of MS is being investigated, particularly in patients whose disease is not well-controlled with pharmacologic agents.